CannaTech Sydney Speakers & Topics

   
 
Tel Aviv & Sydney, Oct. 23, 2018…CannaTech Sydney, Australia’s first ever Medical Cannabis Summit will highlight the biggest industry thought leaders known for their significant and ground-breaking contributions to the exploding global cannabis market in all fields. CannaTech covers a wide breadth of the most current industry topics agenda including presentations that cover Medical Science, Technology, Investment, International Regulation and more.
 
Participants from around the world will gather at Doltone House, Darling Island. The summit will be preceded on October 28 by a special Cannabis Business Symposium.
 
 
Journalists and photographers must register in advance!
 
NOTE: There will be an on-site PRESS BRIEFING with CannaTech CEO Saul Kaye and several top international and Australian medical cannabis leaders on Monday, October 29, 11:15-11:45 am.  Check with registration desk to confirm location.
 
 
Following is a schedule of topics and speakers. Schedule subject to change.
 
Sunday September 28, Business Symposium
 
14:00 - 14:30
Global Investment Trends and Forecasts: A Macro Assessment of the APAC Cannabis Market
John Kagia/ Chief Knowledge Officer, Industry Analytics, New Frontier Data
 
 
 
14:30 - 15:00
Business Keynote: Making Sense of the Surging Global Cannabis Market
Bruce Linton, Founder, Chairman and Co-CEO, Canopy Growth
 
 
 
15:00 - 15:30
How to Stay Competitive in an Expanding Global Market (the branding & marketing of medical cannabis)
Brad Gobel, Director of Regulated Industries, Shopify 
Chris-Driessen, Partner; President, Organa Brands U.S.
Jeremy-Heid, Co-Founder; President, Organa Brands International
 
 
 
15:30 - 16:00
Cannabusiness and Academia; Building for the Next Generation
Nitin Mantri, Associate Professor, RMIT University 
Ron Lipsky, VP of Business Development, MGC Pharma
 
 
16:30 - 16:50
Going Global: Cannabis Business Opportunities in Latin America
Alfredo Pascual, International Analyst, Marijuana Business Daily
 
 
 
16:50 - 17:00
Wholesale Cannabis Merchant Trading Platform Experience
Saul Singer, Co-Founder & CEO of CMTREX
 
 
17:00 - 17:30
An In-depth Look at European Medical Cannabis
 
 
17:30 - 17:45
Constance Finley, Founder and CEO, Constance Therapeutics
 
 
17:45 - 18:15
Regulation’s Role in Global Partnerships & Cannabis Business Decisions
Deepak Anand, VP, Business Development & Government Relations, Cannabis Compliance Inc. 
Pat McCutcheon, President and CEO, MediPharm
Elaine Darby, Managing Director, AusCann Group Holdings Ltd
Lynn Honderd, Co-Founder & CEO, Mary
 
 
18:15 - 18:45
Panel: Capital Market, The How and Why of Going Public
Stephen Silver/ Managing Director, Hunter Capital Advisors Director, Capital Markets, TheraCann International Benchmark Corporation 
Jeremy Leibler, Partner, Arnold Bloch Leibler
 
 
18:45 - 19:00
Cannabis Investment Overview: Fear, Risk & How to Spot a Winner
Brian Sheng, General Partner, Arcview Group
 
 
19:00
Closing Remarks
Saul Kaye, CEO, Founder of iCAN: israel cannabis
 
Monday, October 29, Summit Day 1
 
9:30 - 09:45
Lorne Gertner, Chairman & Co-Founder, Hiku Brands Company Ltd.
Helen Kapalos, Chairperson, Victorian Multicultural Commission
 
 
09:45 - 10:00
The Ethnopharmacological History of Cannabis
Justin Sinclair, Research Fellow, NICM
 
 
10:00 - 10:30
Policy & Regulation Panel: Getting on the Map in Global Medical Cannabis Policy and Next Steps for Australia
Deepak Anand, VP, Business Development & Government Relations, Cannabis Compliance Inc. 
Mimi Busk Downey, Director of Regulatory Affairs, TheraCann International Benchmark Corporation 
Jonathan Zaid, Director of Advocacy and Corporate Social Responsibility, Aurora
Carol Ireland, CEO and Managing Director, Epilepsy Action Australia
 
 
10:30 - 10:45
Humans of Medical Cannabis: The Road to 'Rylie's Law'
Rylie Maedler, President & Founder, Rylie's Sunshine
 
 
10:45 - 11:15
Pharma 2.0 – Exploring the Development of Cannabis as Medicine
Dr. Guy Chamberland, CSO & Regulatory Affairs, Tetra Bio-Pharma 
Constance Finley, Founder and CEO, Constance Therapeutics 
Sharlene Mavor, Medical Cannabis Research Australia (NFO)  
Dr. Melanie Kelly, Professor, Dalhousie University, Canada
 
 
11:45 - 12:00
Macro Trends on Global Cannabis Market (Including CBD)
Giadha Decarcer, Founder & CEO, New Frontier Data
 
 
12:00 - 12:30
All Star Canadian Panel
Vinay Tolia/ CEO, The Flowr
Joshua Eades, Vice President, Chief Science Officer, Tilray 
Pradyum Sekar, CEO, Sail Cannabis
 
 
12:30 - 12:45
Beyond Physician and Patient Education
Pradyum Sekar, CEO, Sail Cannabis
 
 
12:45 - 13:15
Global Insights Panel
Cam Battley, Chief Corporate Officer, Aurora Cannabis 
Dr. Stewart Washer, VP Business Development, AusCann Ltd
 
 
13:15 - 13:30
Nutraceutical, Cannaceutical, and Pharmaceutical
Stephane Redey, Scientific Industry Advisor, PhD, Creso Pharma
 
 
14:30 - 15:00
Effecting Change: The Advocates' Road to Compassionate Care
Alice Oleary Randall, Medical Cannabis Pioneer, Editor-in-Chief, Mary's
Lucy Haslam, Executive Director, Co-Founder, United in Compassion 
Lynn Honderd, Co-Founder & CEO, Mary
 
 
15:00 - 15:15
Cannabis & Cancer Research
Prof. Marco Falasca, Professor, School of Pharmacy and Biomedical Sciences, Curtin University
 
 
15:15 - 15:30
The PELICAN study: Results and Implications for Policy
Anastasia Suraev, Clinical Research Officer, Lambert Initiative for Cannabinoid Therapeutics
 
 
15:30 - 15:50
Australia’s First Producer
Fleta Solomon, Managing Director, Little Green Pharma
 
 
15:45 - 16:05
Navigating Australia’s Cannabis Landscape
Paul Mavor, Director, Health House and Medical Cannabis Research Australia
 
 
 
16:05 - 16:30
Using Microbes in Commercial Cannabis Cultivation
Colin Bell, Chief Growth Officer, Growcentia
 
Tuesday October 30, Summit Day 2
 
09:30 - 9:45
Next Gen Research: Clinical Research Programs Including Soon-to-be-Published Driving Data
Prof Iain McGregor, Academic Director, Lambert Initiative for Cannabinoid Therapeutics
 
 
09:45 - 10:10
The Methodology of Studying and Doing Cannabis Research
Dy. Ryan Vandrey, Associate Professor, Johns Hopkins University
 
 
10:10 - 10:35
The Regulation of the Cultivation and Manufacture of Medicinal Cannabis Products
John Skerritt, Adjunct Prof FTSE FIPAA (Vic), Deputy Secretary, Department of Health, Australia
 
 
10:35 - 10:55
Chemotype Variance and the Relation to Clinical Health Outcomes
Andrew Samann, CEO and Founder, Orion GMP Solutions
 
 
11:00 - 11:15
Potential of Cannabis-Based Medicines to Treat Psychiatric Illness and Improve Brain Health
Dr. Katrina Green, Researcher, Lecturer, University of Wollongong
 
 
11:45 - 12:00
From Hemp to Cannabis: Around the World in Two Decades
Paul Benhaim, Executive Director and CEO, Elixinol Global Limited
 
 
12:00 - 12:15
Expert Research on Cannabis for Epilepsy
Prof. Uri Kramer, Scientific Advisor, MGC Pharma
 
 
12:15 - 12:30
Medical Research: Cancer and Full-spectrum Products, CBD:THC Synergy and Pain
Jonathan Arnold, Associate Professor, Lambert Initiative for Cannabinoid Therapeutics
 
 
 
12:30 - 12:50
T​he Education and Administration of Medical Cannabis Treatment for Paediatric Care
Naama Saban, RN BcS, Medifarm
 
 
 
12:50 - 13:10
Patient Centric Consumer Trends: Canadian Data Tells the Story
Matei Olaru, CEO, Lift & Co.
 
 
13:10 - 13:30
Health, Science and Policy: A Patient First Agenda
Dr. Mark Ware, Chief Medical Officer, Canopy Growth
 
 
14:30 - 14:50
The Importance of Maintaining an Honest Business
Charles Feldmann,  Head of International Cannabis Team, Cantafio Feldmann Nagel
 
 
14:50 - 15:10
Ensuring a Reliable, Economic, Practical and Safe Cannabis Regulatory Framework
Chris Bolton, COO and Founder, TheraCann International Benchmark Corporation
 
 
15:10 - 15:30
Lessons from Canada: Medical Education and the Road Forward for Medical Cannabis in Australia
Daniel Schecter, Co-founder & Medical Director of the Canadian Cannabinoid Medical Clinic
 
 
16:00 - 16:15
Science & Medicine: Next Steps in Cannabis Extraction Technology
Pat-McCutcheon, President and CEO, MediPharm Labs
 
 
16:30 - 17:00
3 Under 30: The Future of Australian Medical Cannabis
Adam Miller, Founder and CEO, BuddingTech 
Rhys Cohen/ Project Officer, Lambert Initiative for Cannabinoid Therapeutics
 
Australian Media Contact for interviews, media enquiries and registration:
Candice Meisels
candice@candicepr.com
 
To register and for further information contact Laura Kam, laura@kamgs.com, 972-54-806-8613.